Authors: Baran, KW Nguyen, M McKendall, GR Lambrew, CT Dykstra, G Palmeri, ST Gibbons, RJ Borzak, S Sobel, BE Gourlay, SG Rundle, AC Gibson, CM Barron, HV

Citation: Kw. Baran et al., Double-blind, randomized trial of an Anti-CD18 antibody in conjunction with recombinant tissue plasminogen activator for acute myocardial infarction - Limitation of myocardial infarction following thrombolysis in acute myocardial infarction (LIMIT AMI) study, CIRCULATION, 104(23), 2001, pp. 2778-2783

Authors: Shindler, DM Palmeri, ST Antonelli, TA Sleeper, LA Boland, J Cocke, TP Hochman, JS

Citation: Dm. Shindler et al., Diabetes mellitus in cardiogenic shock complicating acute myocardial infarction: A report from the SHOCK Trial Registry, J AM COL C, 36(3), 2000, pp. 1097-1103

Authors: Sanborn, TA Sleeper, LA Bates, ER Jacobs, AK Boland, J French, JK Dens, J Dzavik, V Palmeri, ST Webb, JG Goldberger, M Hochman, JS

Citation: Ta. Sanborn et al., Impact of thrombolysis, intra-aortic balloon pump counterpulsation, and their combination in cardiogenic shock complicating acute myocardial infarction: A report from the SHOCK Trial Registry, J AM COL C, 36(3), 2000, pp. 1123-1129